Stocks Health care CCEL
NYSE · Health careCryo Cell International Inc (CCEL)
Cryo Cell International Inc brought in $31.1M of revenue over the twelve months to May 31, 2026, down 2.7% from a year earlier. It posted a net loss of $2.5M. Operating cash flow minus capital spending left $5.2M of free cash flow in fiscal 2025. At May 31, 2026 it held $507.3K in cash against $8.3M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 15, 2026.
What Cryo Cell International Inc does
Cryo Cell International Inc is registered with the SEC under industry code SIC 8090 (Services-Misc Health & Allied Services, NEC). Its shares trade on NYSE under the ticker CCEL.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $31.6M | -$2.4M | -$0.30 | $5.2M |
| 2024 | $32M | $402.1K | $0.05 | $3.6M |
| 2023 | $31.3M | -$9.5M | -$1.14 | $2.1M |
| 2022 | $30.3M | $2.8M | $0.33 | -$3.6M |
| 2021 | $28.9M | $2.1M | $0.25 | $6.1M |
| 2020 | $31.1M | $3.6M | $0.45 | $8.4M |
Full financial statements: income, balance sheet and cash flow
Where CCEL ranks in Health care
Dividends
It paid out $3.2M in cash dividends.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | n/a | $3.2M | n/a |
| 2024 | $0.25 | $2M | 503% |
| 2023 | n/a | $0 | n/a |
| 2022 | $0.90 | $7.7M | 277% |
| 2021 | n/a | $0 | 0% |
Latest SEC filings
What Cryo Cell International Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 14, 2026Other event 8-K
- July 15, 2026Quarterly report 10-Q · period to May 31, 2026Revenue fell 1.9% to $7.8M versus the same quarter last year; diluted EPS $0.07 versus $0.04.
- July 7, 2026Activist stake changed SCHEDULE 13D/A
- May 8, 2026
- April 14, 2026Quarterly report 10-Q · period to February 28, 2026Revenue fell 3.6% to $7.7M versus the same quarter last year; diluted EPS $0.01 versus $0.03.
- March 25, 2026Activist stake (5% or more) SCHEDULE 13D
- March 12, 2026
- February 27, 2026Annual report 10-K · period to November 30, 2025Revenue fell 1.3% to $31.6M versus the prior year; diluted EPS -$0.30 versus $0.05.
- November 12, 2025Other event 8-K
- October 23, 2025
What is CCEL worth? A DCF from its reported cash flow
Insider trades
What the people running Cryo Cell International Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 2 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 5, 2026 | Portnoy DavidChairman, Co-CEO, Director, 10% owner | Other change | 600,191 | $800K |
| August 5, 2026 | Portnoy DavidChairman, Co-CEO, Director, 10% owner | Other changeindirect | 600,191 | $800K |
| May 28, 2026 | Taymans Jill MVP Finance, CFO | Exercised options | 7,500 | $23.3K |
Who owns CCEL
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Camac Partners, LLC13D, may seek influence with 3 related filers | 6.8% | July 7, 2026 |
Largest institutional holders
Insiders
2 insiders reported holding 900,525 shares in total, about $3.8M at the last price.
| Holder | Shares |
|---|---|
| Portnoy DavidChairman, Co-CEO, Director, 10% owner | 847,629600,191 held indirectly |
| Taymans Jill MVP Finance, CFO | 52,896 |
Questions about CCEL
What does Cryo Cell International Inc do?
Cryo Cell International Inc is registered with the SEC under industry code SIC 8090 (Services-Misc Health & Allied Services, NEC). Its shares trade on NYSE under the ticker CCEL.
Is Cryo Cell International Inc profitable?
No. Over the twelve months to May 31, 2026 it reported a net loss of $2.5M on revenue of $31.1M.
How much revenue does Cryo Cell International Inc make?
Over the twelve months to May 31, 2026 Cryo Cell International Inc reported revenue of $31.1M. That is 2.7% less than a year earlier.
When did Cryo Cell International Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on July 15, 2026. It covers the period to May 31, 2026. Its newest filing of any kind is the other event from September 14, 2026.
Similar companies
Compare CCEL with
Follow CCEL
Get an email when Cryo Cell International Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow CCEL: get an email when it filesWhere the numbers come from
Financial figures are the values Cryo Cell International Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.